Objective-To determine the functional significance of physiological reactive oxygen species (ROS) levels in endotheliumdependent nitric oxide (NO)-mediated coronary vasodilatation. Methods and Results-Endothelium-derived NO is important in regulating coronary vascular tone. Excess ROS have been shown to reduce NO bioavailability, resulting in endothelial dysfunction and coronary diseases. NADPH oxidase is a major source of ROS in endothelial cells (ECs). By using lucigenin-based superoxide production and dichlorfluorescein diacetate (DCFH-DA) fluorescence-activated cell sorter assays, we found that mouse heart ECs from NADPH oxidase-knockdown (p47 phoxϪ/Ϫ ) animals have reduced NADPH oxidase activity (Ͼ40%) and ROS levels (Ͼ30%) compared with wild-type mouse heart ECs. Surprisingly, a reduction in ROS did not improve coronary vasomotion; rather, endothelium-dependent vascular endothelial growth factor-mediated coronary vasodilatation was reduced by greater than 50% in p47 phoxϪ/Ϫ animals. Western blots and L-citrulline assays showed a significant reduction in Akt/protein kinase B (PKB) and endothelial NO synthase phosphorylation and NO synthesis, respectively, in p47 phoxϪ/Ϫ coronary vessels and mouse heart ECs. Adenoviral expression of constitutively active endothelial NO synthase restored vascular endothelial growth factor-mediated coronary vasodilatation in p47 phoxϪ/Ϫ animals. Conclusion-Endothelium-dependent vascular endothelial growth factor regulation of coronary vascular tone may require NADPH oxidase-derived ROS to activate phosphatidylinositol 3-kinase-Akt-endothelial NO synthase axis. (Arterioscler Thromb Vasc Biol. 2010;30:1703-1710.)
R eactive oxygen species (ROS) include molecules that have unpaired electrons, such as superoxide (O 2 •Ϫ ), hydroxyl anion (HO Ϫ ), and nitric oxide (NO Ϫ ); or that have the oxidizing ability but do not possess free electrons, such as hydrogen peroxide (H 2 O 2 ), hypochlorous acid, and peroxynitrite. ROS have long been implicated in the pathogenesis of cardiovascular diseases, including hypertension, atherosclerosis, diabetic vasculopathy, and heart failure. [1] [2] [3] However, recent findings 4 -13 suggest that ROS play critical roles in signal transduction in vascular cells, including endothelial cells (ECs). Researchers 14 -17 have identified NADPH oxidase as a major source of superoxide in ECs, thus 1 of the important determinants of the oxidation-reduction (redox) state of the endothelium. The NADPH oxidase-enzyme complex consists of 2 membrane-bound components (gp91 phox [also known as NADPH oxidase (Nox)-2] and p22 phox ) and several cytosolic regulatory subunits, including p47 phox , p67 phox , and the small GTPase Rac (Rac1 or Rac2). On enzyme activation, the cytoplasmic subunits translocate to the cell membrane and the resulting complex transfers electrons from NADPH to molecular oxygen to form O 2 •Ϫ . More recently, NADPH oxidase-derived ROS have also been implicated in EC proliferation, migration, and angiogenesis. 14, 15, 17 ROS-mediated vascular dysfunction is, in part, caused by reduction in NO Ϫ bioavailability as the result of redox (O 2 •Ϫ )-catalyzed formation of peroxynitrite. 18 -22 NO plays important roles in several vascular functions, including regulation of vasomotor tone and maintenance of vascular health. 23, 24 Endothelial NO synthase (eNOS) can be stimulated to produce NO by hemodynamic forces, hormones, cytokines, and growth factors, including vascular endothelial growth factor (VEGF). Once NO diffuses from the endothelium into the adjacent vascular smooth muscle cell layer, NO mediates vasorelaxation and regulates the balance between vascular smooth muscle cell proliferation and apoptosis; this later function governs important aspects of vessel caliber and remodeling. 24 NO-induced vasodilatation occurs via activation of soluble guanylyl cyclase, thereby elevating cGMP levels. 24 Indeed, mice deficient in eNOS demonstrated impaired endothelium-dependent relaxation in conduit arteries. 25 NO also exerts its effects on the cardiovascular system by S-nitrosylation of protein thiols in a cGMP-independent manner. 26 -28 As a major source of endothelial superoxide, increases in NADPH oxidase activity contribute to the impairment of endothelium-dependent vasodilatation by reducing NO Ϫ levels. The resultant endothelial dysfunction is believed to be involved in the pathophysiology of vascular diseases. 29 Thus, the balance between ROS and NO is critical for optimal endothelial and vascular function.
VEGF plays important roles in vascular protection, 30, 31 hemostasis, 32,33 microvascular permeability, 34 -36 wound repair, 37 and angiogenesis of ischemic tissue 38, 39 ; and also regulates vasomotor tone by regulating eNOS activity. 40 -44 In ECs, VEGF induces NO production through phosphatidylinositol 3-kinase (PI3K)-Akt-mediated phosphorylation of eNOS at S1179. 40, 41, 45 Researchers 14 -17 have previously reported that VEGF induces NADPH oxidase activity and that NADPH oxidase-derived ROS are essential for VEGF-mediated EC functions in vitro. Recently, it was demonstrated that VEGF-mediated activation of PI3K-Akt, but not extracellular signal-regulated kinase (ERK) 1/2, depends on NADPH oxidase-derived ROS in human coronary artery ECs in vitro. 46 These findings present an interesting paradox: although ROS are required for VEGFmediated activation of PI3K-Akt signaling that lies upstream of eNOS, ROS can also reduce the bioavailability of NO. Thus, the functional outcome of physiological levels of endogenous ROS is not precisely known. Questions include whether ROS exert negative effects on NO bioavailability or whether they enhance NO levels by activating eNOS through VEGF-PI3K-Akt. The goal of the present study is to examine the functional consequence of a decrease in physiological NADPH oxidase activity on VEGF-mediated coronary vasodilatation. Herein, we report the finding that a reduction in NADPH oxidase-derived ROS inhibits VEGF-mediated endothelium-dependent relaxation of coronary vessels in NADPH oxidase knockdown (p47 phoxϪ/Ϫ ) mice. We also demonstrate that the defect in vasomotion is the result of reduced activation of PI3K-Akt-eNOS signaling in these vessels.
Methods

Mouse Heart EC Isolation and Culture
Mouse heart ECs (MHECs) were isolated from the heart specimens of 3-week-old animals, as previously described. 47 For each experiment, primary cultures of both genotypes were started simultaneously from 2 animal hearts each.
Also, NADPH oxidase activity and intracellular levels of ROS were determined in MHEC, as previously described. 14, 15, 46, 48 
Ex Vivo Coronary Microvessel Relaxation Studies
After cardiac harvest from 6-to 8-week-old mice, coronary arterioles (diameter, 80 to 120 m; length, 2 mm) from wild-type (WT) C57BL/6 (nϭ6) and p47 phoxϪ/Ϫ (nϭ8) mice were dissected from the surrounding tissue. Microvessel studies 49 -51 were performed using in vitro organ bath videomicroscopy, as previously described. Where indicated, isolated coronary vessels were pretreated with membranepermeant ROS scavengers (4-hydroxy-2,2,6,6-tetramethylpieradine-1-oxyl [TEMPOL], 1 mol/L) and manganese (Mn) (III)tetrakis (4-benzoic acid)porphyrin chloride (MnTBAP, 1 mol/L) (EMD Bioscience, Darmstadt, Germany). More details can be found in the supplemental data (available online at http://atvb.ahajournals.org).
eNOS Activity Assay
Mouse heart specimens were harvested and homogenized in 20 mL of ice-cold homogenization buffer (25-mmol/L Tris⅐Cl, 1-mmol/L EDTA, and 1-mmol/L EGTA, pH 7.4) per gram of tissue. eNOS activity was determined using the NOS assay kit (CalBiochem, San Diego, Calif) that measures conversion of L-[ 3 H]arginine to L-[ 3 H]citrulline, according to the manufacturer's directions. Detailed methods can be found in the supplemental data.
Western Blot Analyses
Mouse whole hearts and coronary vessels with surrounding cardiac tissues were harvested separately for total protein content. Western blots were performed as previously described. 52, 53 Coronary vessels from 2 hearts were pooled for each sample. Antiphosphorylated (473) Akt, antiphosphorylated (1179) eNOS, antiphosphorylated ERK1/2, anti-Akt, and anti-eNOS antibodies were obtained from Cell Signaling (Beverly, Mass). MHECs were grown on gelatin-coated plates to 80% or 90% confluence, serum starved for 24 hours, and then treated with VEGF, 100 ng/mL, for the times indicated. Cell lysates were prepared for Western blot analysis, as previously described. 46 
Adenoviruses and Expression of Constitutively Active S1179D eNOS in Coronary Vessels
Replication-deficient adenoviruses encoding the cDNAs of ␤-galactosidase (adenovirus-␤-galactosidase gene [Ad-lacZ]), green fluorescent protein (GFP) (Ad-GFP), and S1179D eNOS (Ad-S1179D eNOS-GFP) were previously described. 41, 54, 55 p47 phoxϪ/Ϫ mice, aged 6 to 8 weeks, underwent in situ coronary artery perfusion with replication-deficient adenovirus encoding control genes (Ad-lacZ and Ad-GFP) or adenovirus (Adv)-S1179D eNOS. 56, 57 Mice were anesthetized, exsanguinated, and perfused with saline via infusion into the apex of the left ventricle. Recombinant adenovirus, 5ϫ10 9 plaque-forming units, in 0.9% saline was then perfused into the aortic root in a retrograde fashion at 40 L/min over 20 minutes. The heart was explanted and cultured in DMEM supplemented with 10% fetal calf serum, 100-U/mL penicillin, 100-g/mL streptomycin, 2.5-g/mL amphotericin, and 25g/mL gentamicin for 16 hours at 37°C and 5% CO 2 . The supplemental data provide further details; supplemental materials also describe the results of immunohistochemical analyses.
Statistical Analyses
Data are given as the meanϮSEM, where appropriate. PϽ0.05 between experimental groups was considered a significant difference. Nonlinear regression modeling using the extra sum-of-squares F test to compare slopes (Prism 5, Graph Pad Software) was used to analyze microvessel reactivity data.
Results p47 phox؊/؊ MHECs Have Reduced NADPH Oxidase Activity and ROS Levels
First, we wanted to determine the levels of NADPH oxidase activity and total ROS in ECs of genetically modified p47 phox subunit-knockout (p47 phoxϪ/Ϫ ) animals. By using a low concentration-based lucigenin assay and dichlorfluorescein (DCF)-DA-based fluorescence-activated cell sorter analysis, we determined a 41.0Ϯ4.7% reduction in NADPH oxidase activity ( Figure 1A ) and a 32.2Ϯ6.4% reduction in total ROS levels ( Figure 1B ) in p47 phoxϪ/Ϫ MHECs compared with WT MHECs. These findings suggest that endothelial NADPH oxidase activity and ROS levels are significantly reduced in the absence of p47 phox .
VEGF-Induced Vasodilatation Is Inhibited in Coronary Vessels of p47 phox؊/؊ Mice
Endothelium-dependent vasodilatation is dependent on NO bioavailability. Because MHECs from p47 phoxϪ/Ϫ mice have significantly reduced NADPH oxidase activity and ROS, we wanted to examine endothelium-dependent coronary vasodilatation in these animals. Surprisingly, VEGF-induced coronary vasodilatation was reduced by 50.0Ϯ6.4% in p47 phoxϪ/Ϫ mice compared with WT mice (Figure 2A ). This apparently counterintuitive finding led us to examine whether NO production in endothelium and NO response in vascular smooth muscle cells are intact in p47 phoxϪ/Ϫ mice. Thus, coronary arterioles from WT and p47 phoxϪ/Ϫ mice were subject to relaxation responses to ADP, a nucleotide that releases NO from the endothelium in a PI3K-Akt-independent manner 58 ; and to sodium nitroprusside (SNP), an NO donor that acts directly on vascular smooth muscle. ADP Ϫ ( Figure 2B ) and SNP-induced ( Figure 2C ) vasodilatation of the coronary arterioles from p47 phoxϪ/Ϫ mice was comparable to that of WT animals, suggesting that the ability of the endothelium to produce NO in response to non-VEGF stimuli and that the response of smooth muscle cells to NO in these vessels were unaffected. Furthermore, the endothelium dependence of VEGF-and ADP-mediated, but not SNP-mediated, vasodilatation was confirmed by endothelial denudation in WT coronary vessels, as described in the supplemental methods. Taken together, these findings suggest that VEGF-stimulated endothelium-dependent vasodilatation is specifically affected in the coronary blood vessels in p47 phoxϪ/Ϫ mice.
PI3K-Akt-eNOS Signaling and NO Synthesis Are Reduced in Coronary Vessels of p47 phox؊/؊ Mice
NO synthesis in the endothelium is known to be induced by PI3K-Akt-mediated activation of eNOS. 59 -61 Recently, it was demonstrated that VEGF-mediated activation of PI3K- Akt is dependent on NADPH oxidase-derived ROS in human ECs in vitro. 46 Combined with our current findings, this led us to examine whether the observed defect in coronary vessel relaxation in p47 phoxϪ/Ϫ mice resulted from reduced basal activation of redox-sensitive PI3K-Akt-eNOS. To test this, we measured activation levels of PI3K-Akt-eNOS signaling and NO levels in p47 phoxϪ/Ϫ coronary vessels using Western blots and citrulline assays, respectively. Figure 3A demonstrates that phosphorylation levels of Akt and eNOS in p47 phoxϪ/Ϫ coronary vessels are reduced by 61.0Ϯ4.8% and 34.5Ϯ6.3%, respectively, compared with that of WT mice. NO synthesis in coronary vessels of p47 phoxϪ/Ϫ mice was also reduced by 30.8Ϯ4.2% compared with that of WT mice ( Figure 3B ). These findings suggest that genetic deletion of the NADPH oxidase subunit, p47 phox , results in reduced activation of PI3K-Akt-eNOS signaling and NO synthesis in the coronary vasculature. However, there was no difference in the expression levels of VEGF receptors 1 and 2 (supplemental Figure IA ) or phosphorylation levels of ERK1/2 ( Figure 3A ) in coronary vessels of WT and p47 phoxϪ/Ϫ mice, suggesting that NADPH oxidase activity selectively modulates the PI3K-Akt-eNOS pathway.
VEGF-Induced Activation of PI3K-Akt-eNOS, But Not ERK1/2, Is Inhibited in p47 phox؊/؊ MHECs
Next, we wanted to examine whether VEGF-induced activation of PI3K-Akt-eNOS signaling required NADPH oxidase activity in murine endothelium. We performed Western blots for the phosphorylation of Akt, eNOS, and ERK1/2 using cell lysates from WT and p47 phoxϪ/Ϫ MHECs. VEGF-induced phosphorylation of Akt and eNOS, but not ERK1/2, was inhibited in MHECs from p47 phoxϪ/Ϫ mice, suggesting that selective activation of PI3K-Akt-eNOS by VEGF depends on NADPH oxidase activity in murine ECs (supplemental Figure  IB) . However, there was no difference in the expression levels of VEGF receptors 1 and 2 between WT and p47 phoxϪ/Ϫ MHECs (supplemental Figure IA) . These results suggest that the VEGF-PI3K-Akt-eNOS (but not ERK1/2) axis in MHECs is dependent on NADPH oxidase activity.
Expression of Activated eNOS Compensates for p47 phox؊/؊ Effects on Coronary Vasodilatation
To examine whether reduced activation of PI3K-Akt-eNOS is responsible for the inhibition of VEGF-induced vasodilatation, we introduced replication-deficient control adenovirus (Ad-lacZ or Ad-GFP) or adenovirus expressing constitutively active eNOS (Ad-S1179D eNOS-GFP) 41 into the coronary vessels of p47 phoxϪ/Ϫ mice (Figure 4) , as described in the supplemental methods. Gene transfer to the endothelium was confirmed by ␤-galactosidase staining (data not shown) and coimmunofluorescence staining for GFP and anti-CD31 ( Figure 4A ). Overexpression of eNOS in the endothelium of the Ad-S1179D eNOS-transduced coronary vessels was further confirmed by Western blots ( Figure 4B ) and immunohistochemistry ( Figure 4C ). Ad-S1179D eNOStransduced p47 phoxϪ/Ϫ coronary vessels demonstrated a 1.84Ϯ0.22-fold increase in eNOS activity compared with Ad-GFP-transduced vessels, as measured by the citrulline assay ( Figure 4D ).
Finally, we examined whether expression of activated eNOS in the endothelium of intact coronary blood vessels could compensate for the reduced vasodilatory activity in NADPH oxidase knockdown mice. Figure 5A demonstrates that expression of activated eNOS (recombinant adenovirus [rAd].S1179D NOS3) restored VEGF response in the coronary vessels of p47 phoxϪ/Ϫ mice to the WT levels. Together, these findings suggest that activation of PI3K-Akt-eNOS signaling is inhibited in p47 phoxϪ/Ϫ coronary vessels, which results in defective vasodilatation in response to VEGF.
Reduction in ROS Inhibits VEGF-Induced Coronary Vasodilatation
Next, we wanted to test whether ROS have a direct role on VEGF-induced coronary vasodilatation. To that end, we treated the coronary arteries of WT mice with 2 different cell-permeant ROS scavengers, TEMPOL (broad-spectrum free radical scavenger) and MnTBAP (superoxide scavenger/dismutase that does not scavenge NO), and measured VEGF-induced vasodilatation. Both TEMPOL and MnTBAP significantly inhibited VEGFinduced coronary vasodilatation ( Figure 6 ), but not SNPmediated vasodilatation (data not shown), providing direct evidence that decreasing ROS impairs endothelium-dependent coronary vasodilatation. Although TEMPOL decreases ROS levels, MnTBAP specifically reduces superoxide levels by converting O 2 •Ϫ to H 2 O 2 and, thus, increases overall H 2 O 2 levels. The inhibitory effects of both TEMPOL and MnTBAP suggest a greater role for superoxide compared with H 2 O 2 in VEGF-induced coronary vasodilatation. However, our data cannot exclude the requirement for proper subcellular localization of H 2 O 2 in VEGF-induced activation of signaling pathways and coronary vasodilatation. Future studies will address these important questions.
Discussion
The goal of the present study was to determine the role of endogenous NADPH oxidase-derived ROS (ie, physiological levels of ROS in coronary vascular function). Specifically, we wanted to examine whether reduction in endogenous NADPH oxidase activity would improve coronary vascular function (eg, vasodilatation, by increasing NO bioavailability). To that end, we have used an NADPH oxidaseknockdown mouse model (p47 phoxϪ/Ϫ ) that has significantly reduced ROS levels in the coronary endothelium. The results presented herein using intact coronary blood vessels and isolated MHECs suggest that endothelium-dependent coronary vasodilatation operates through NADPH oxidase-mediated activation of PI3K-Akt-eNOS signaling and NO synthesis in ECs. To our knowledge, these data also provide the first Figure 4 . Adenoviral expression of constitutively active S1179D-eNOS in the coronary vessels of p47 phoxϪ/Ϫ mice. A, Expression of constitutively active GFP-tagged S1179D-eNOS by gene transfer in the coronary vessels of p47 phoxϪ/Ϫ mice. Cross section of coronary arteries demonstrating negative control (Ad-lacZ; upper panels) and GFP fluorescence (Ad-S1179D-eNOS-GFP; lower panels) in the endothelium. Colocalization of the endothelium is shown using anti-CD31 antibody immunofluorescence (red). Green indicates GFP; blue, 4Ͻ Ͻ,6-diamidino-2-phenylindole (DAPI) (nuclei); arrow, blood vessel. B, Expression of eNOS protein as detected by Western blot analysis in p47 phoxϪ/Ϫ coronary vessels transduced with Ad-GFP or Ad-S1179D-eNOS. Protein extracts from 2 pooled hearts were used for each experiment. The membrane was stripped and reprobed using anti-Akt antibody as loading control. p-indicates phosphorylated. C, Expression of eNOS protein in the coronary vessels transduced with control (Ad-GFP) or Ad-S1179D-eNOS was detected by immunohistochemistry using anti-eNOS antibody. D, NO production was 1.8-fold higher in Ad-S1179D-eNOS-transduced p47 phoxϪ/Ϫ coronary vessels compared with Ad-GFP. All experiments were performed in triplicate. Data are given as meanϮSEM. *PϽ0.05. evidence that reduction in endogenous NADPH oxidase activity can result in coronary vascular dysfunction by decreasing redox-mediated activation of eNOS.
Our data demonstrate that genetic knockdown of NADPH oxidase subunit, p47 phox , results in significant decrease in NADPH oxidase activity and ROS levels in coronary blood vessels. We also show that coronary vessels of these animals have reduced PI3K-Akt-eNOS activity, NO production, and VEGF-induced vasodilatation. Interestingly, coronary vasodilatation by ADP, a PI3K-Akt-independent activator of eNOS, 58 was unaffected in p47 phoxϪ/Ϫ mice, providing additional support for the specificity of the defective VEGF activation of the PI3K-Akt-eNOS axis in this animal. Furthermore, our results demonstrate that VEGF-induced activation of PI3K-Akt-eNOS, but not ERK1/2, signaling is impaired in NADPH oxidase-knockdown MHECs. These findings are in accordance with a previous report 46 that VEGF-mediated activation of PI3K-Akt-forkhead signaling, but not ERK1/2, is dependent on NADPH oxidase activity in human coronary artery ECs in vitro. Taken together, we hypothesize that NADPH oxidase-derived ROS modulate activation of PI3K-Akt-eNOS in endothelium and, thus, regulate VEGF-induced coronary vasodilatation. Our data demonstrating that expression of activated eNOS compensates for the functional loss of upstream PI3K-Akt-eNOS activity in p47 phoxϪ/Ϫ coronary vessels support this hypothesis. Future studies aimed at modulating coronary vasodilatation using loss-of-function or gain-of-function mutants of eNOS-activating signaling intermediates (eg, Akt, PI3K, or cellular sarcoma [c-Src]), including upstream serine and threonine kinases (eg, protein kinase C␦, AMP-activated protein kinase, and protein kinase A), should further our understanding about their individual contributions to ROSmediated eNOS activity and, thus, the regulation of coronary vasomotor tone.
ROS have been previously shown to increase NO release in blood vessels and in EC culture in vitro. 20, 60, 62 A recent study by Zhang and coworkers 63 reported that superoxide production by overexpression of nox5 increased eNOS activity in aorta and cultured ECs. However, nox5-induced activation of eNOS was mediated through enhanced association of eNOS with heat shock protein-90 without altering eNOS phosphorylation. 63 Another study 64 reported that Rac1 regulated vasomotor response and angiogenesis by transcriptional upregulation of eNOS. To our knowledge, the current study is the first to demonstrate that endogenous NADPH oxidase-derived ROS play an important role in endothelium-dependent vasodilatation in intact coronary blood vessels. Our data also provide evidence for a novel mechanism by which NADPH oxidase-derived ROS modulate PI3K-Akt activation and, thus, regulate downstream phosphorylation and posttranslational activation of eNOS in coronary endothelium. In addition, ROS scavengers inhibited endothelium-dependent coronary vasodilatation in WT animals, providing further support for a positive role for ROS in coronary vasomotion. Figure 5 . A, Activated eNOS expression compensates for the NADPH oxidase knockdown effects on coronary vessels. VEGFinduced endothelium-dependent dilation of coronary arterioles from p47 phoxϪ/Ϫ mice transduced with Ad-GFP (nϭ4) or Ad-S1179D-eNOS (nos3)-GFP (nϭ4). PϽ0.001. B, Proposed model for NADPH oxidase-dependent activation of eNOS and coronary vasodilatation. Reduction in coronary vasodilatation in NADPH oxidase-knockdown mice appears to be because of defective activation of the redox-sensitive VEGF signaling pathway (shown in the colored box), PI3K-Akt-eNOS, in the coronary endothelium. ERK1/2 activation is independent of the redox level in the endothelium. Figure 6 . ROS scavengers inhibit VEGF-induced vasodilatation in coronary vessels of WT mice. Isolated coronary vessels were treated with membrane-permeant ROS scavenger TEMPOL, 1 mol/L, and MnTBAP, 1 mol/L, for 15 minutes. Endotheliumdependent dilation of coronary arterioles from WT (nϭ4) mice in response to VEGF was assayed as described in "Ex Vivo Coronary Microvessel Relaxation Studies" under Methods. section. For statistical significance, nonlinear regression modeling was used to compare slopes (Prism 5, Graph Pad Software) of the microvessel reactivity data.
These results are in contrast with a long-held notion that reduction of ROS will improve global vascular functions by increasing bioavailability of NO. Rather, our data support a critical positive role for endogenous NADPH oxidase-derived ROS in NO production in intact coronary vessels.
In summary, we demonstrate that endothelium-dependent coronary vasodilatation operates through NADPH oxidasederived ROS-mediated activation of PI3K-Akt-eNOS signaling and NO synthesis in endothelium ( Figure 5B ). Together with previous findings using human coronary ECs, 46 the present study suggests that redox sensitivity of PI3K-Akt-eNOS signaling may be evolutionarily conserved in mammalian coronary vessels. The redox dependence of eNOS in the coronary vasculature may have the following important functional implications: (1) it may help maintain critical balance between superoxide and NO levels in coronary vessels and, thus, ensure NO bioavailability during oxidative stress; (2) it may synchronize peroxynitrite levels with redox content of the vasculature; and (3) it may represent a coordinated feedback loop that enhances eNOS activity by ROS to counterbalance reduction in NO bioavailability. Studies are undergoing to address these important questions.
